Brawn for brains: The role of MEF2 proteins in the developing nervous system

被引:69
作者
Shalizi, AK [1 ]
Bonni, A
机构
[1] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
来源
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 69 | 2005年 / 69卷
关键词
D O I
10.1016/S0070-2153(05)69009-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The myocyte enhancer factor 2 (MEF2) transcription factors were originally identified, as their family name implies, on the basis of their role in muscle differentiation. Expression of the four MEF2 proteins, however, is not restricted to contractile tissue. While it has been known for more than a decade that MEF2s are abundantly expressed in neurons, their contributions to the development and function of the nervous system are only now being elucidated. Interestingly, the emerging mechanisms regulating MEF2 in neurons have significant parallels with the regulatory mechanisms in muscle, despite the quite distinct identities of these two electrically excitable tissues. The goal of this chapter is to provide an introduction to those regulatory mechanisms and their consequences for brain development. As such, we first provide an overview of MEF2 itself and its expression within the central nervous system. The second part of this chapter describes the signaling molecules that regulate MEF2 transcriptional activity and their contributions to MEF2 function. The third part of this chapter discusses the role of MEF2 proteins in the developing nervous system and compares the analogous functions of this protein family in muscle and brain. (c) 2005, Elsevier Inc.
引用
收藏
页码:239 / 266
页数:28
相关论文
共 160 条
[111]   MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells [J].
Ornatsky, OI ;
McDermott, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24927-24933
[112]   A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation [J].
Penn, BH ;
Bergstrom, DA ;
Dilworth, FJ ;
Bengal, E ;
Tapscott, SJ .
GENES & DEVELOPMENT, 2004, 18 (19) :2348-2353
[113]   Mitochondrial mechanisms of neural cell apoptosis [J].
Polster, BM ;
Fiskum, G .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (06) :1281-1289
[114]   Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α):: Transcriptional coactivator and metabolic regulator [J].
Puigserver, P ;
Spiegelman, BM .
ENDOCRINE REVIEWS, 2003, 24 (01) :78-90
[115]  
Puri PL, 2000, GENE DEV, V14, P574
[116]   Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects [J].
Regan, CP ;
Li, W ;
Boucher, DM ;
Spatz, S ;
Su, MS ;
Kuida, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9248-9253
[117]   Regulation and functions of myogenic regulatory factors in lower vertebrates [J].
Rescan, PY .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2001, 130 (01) :1-12
[118]  
Rubin Lee L., 1994, Current Opinion in Neurobiology, V4, P696, DOI 10.1016/0959-4388(94)90012-4
[119]   Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C [J].
Sartorelli, V ;
Huang, J ;
Hamamori, Y ;
Kedes, L .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (02) :1010-1026
[120]  
Schulz RA, 1996, ONCOGENE, V12, P1827